Altering and establishing requirements and prohibitions related to health insurance utilization review, including provisions regarding benchmarks for standardizing and automating the preauthorization process, the online preauthorization system for payors, preauthorizations for prescription drugs, and private review agents; altering timelines related to internal grievance procedures and adverse decision procedures; increasing the penalties for violating certain provisions of law regarding private review agents; etc